International Journal of Hematology

, Volume 79, Issue 3, pp 303–306 | Cite as

Inversions of the Factor VIII Gene in Japanese Patients with Severe Hemophilia A

  • Kazuyoshi Fukuda
  • Hiroyuki Naka
  • Shogo Morichika
  • Masaru Shibata
  • Ichiro Tanaka
  • Midori Shima
  • Akira Yoshioka
Case Report

Abstract

Hemophilia A is genetically very heterogeneous because disease-causing mutations involving deletions, point mutations, insertions, and inversions are scattered throughout the factor VIII gene. Of these mutations, inversions, which are intrachromosomal recombinations between int22h- 1 (intron 22 homologous region 1) and 1 of 2 other extragenic copies located 500 kilobases upstream, are the more frequently found defects, especially in patients with severe hemophilia A. Reportedly, approximately half of all severe hemophilia A patients have inversions in intron 22. A group of unrelated patients from the middle of Japan with severe hemophilia A were screened by Southern blot analysis for gene inversions. Forty-two of 100 severely affected patients presented factor VIII gene rearrangements. Of these patients, 36 exhibited the distal type of inversion, and 6 exhibited the proximal type. No other variant type of recombination was observed. In this study, neither the prevalence of inhibitor development against factor VIII nor the frequency of sporadic cases in the group presenting gene inversions was significantly different from that in the group without chromosomal inversions. Southern blot analysis successfully detected a carrier in a hemophilia family for which no patient was available. Genetic counseling of patients with severe hemophilia A and their families will be considerably improved, because the inversions occur in 42% of the Japanese patients with severe hemophilia.

Key words

Hemophilia A nhibitor Inversion Carrier detection 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wood WI, Gitshier J, Simonsen CC, et al. Characterization of the human factor VIII gene. Nature. 1984;312:330–337.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Toole JJ, Knopf JL,Wozney JM, et al. Molecular cloning of a cDNA encoding human antihaemophilic factor. Nature. 1984;312:342–347.CrossRefPubMedGoogle Scholar
  3. 3.
    Kemball-Cook G, Tuddenham EGD. The factor VIII mutation database on the World Wide Web: the haemophilia A mutation, search, test and resource site: HAMSTeRS update (version 3.0). Nucleic Acids Res. 1997;25:128–132.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Naylor JA, Green PM, Montandon AJ, Rizza CR, Giannelli F. Detection of three novel mutations in two haemophilia A patients by rapid screening of whole essential region of factor VIII gene. Lancet. 1991;337:635–639.CrossRefPubMedGoogle Scholar
  5. 5.
    Higuchi M, Kazazian HH Jr, Kasch L, et al. Molecular characterization of severe hemophilia A suggests that about half the mutations are not within the coding regions and splice junctions of the factor VIII gene. Proc Natl Acad Sci U S A. 1991;88:7405–7409.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Naylor JA, Green PM, Rizza CR, Giannelli F. Analysis of factor VIII mRNA reveals defects in everyone of 28 haemophilia A patients. Hum Mol Genet. 1993;2:11–17.CrossRefPubMedGoogle Scholar
  7. 7.
    Lakich D, Kazazian HH Jr, Antonarakis SE, Gitshier J. Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A. Nat Genet. 1993;5:236–241.CrossRefPubMedGoogle Scholar
  8. 8.
    Naylor J, Brinke A, Hassock S, Green PM, Giannelli F. Characteristic mRNA abnormality found in half the patients with severe haemophilia A is due to large DNA inversions. Hum Mol Genet. 1993;2:1773–1778.CrossRefPubMedGoogle Scholar
  9. 9.
    Naylor JA, Buck D, Green P,Williamson H, Bentley D, Giannelli F. Investigation of the factor VIII intron 22 repeated region (int22h) and the associated inversion junctions. Hum Mol Genet. 1995;4:1217–1224.CrossRefPubMedGoogle Scholar
  10. 10.
    Antonarakis SE, Rossiter JP, Young M, et al. Factor VIII gene inversion in severe hemophilia A: results of an international consortium study. Blood. 1995;86:2206–2212.PubMedGoogle Scholar
  11. 11.
    Schaab R, Brackmann HH, Meyer C, et al. Hemophilia A: mutation type determines risk of inhibitor formation. Thromb Haemost. 1995;74:1402–1406.Google Scholar
  12. 12.
    Shima M, Matsumoto T, Fukuda K, et al. The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia A patients with very low levels of factor VIII activity (FVIII:C). Thromb Haemost. 2002;87:436–441.CrossRefPubMedGoogle Scholar
  13. 13.
    Kamisue S, Shima M, Nishimura T, et al. Abnormal factor VIII Hiroshima: defect in crucial proteolytic cleavage by thrombin at Arg1689 detected by a novel ELISA. Br J Haematol. 1994;86:106–111.CrossRefPubMedGoogle Scholar
  14. 14.
    Sawamoto Y, Shima M, Tanaka I, et al. Anti-factor VIII inhibitor alloantibodies recognizing A2 domain in the human factor VIII heavy chain poorly bind to porcine factor VIII. Int J Hematol. 1997; 65:151–158.CrossRefGoogle Scholar
  15. 15.
    Yoshioka A, Fujimura Y, Yoshioka K, et al. A note on the carrier detection of hemophilia A. Jpn J Hum Genet. 1977;22:261–270.CrossRefGoogle Scholar
  16. 16.
    Naylor JA, Green PM, Rizza CR, Giannelli F. Factor VIII gene explains all cases of haemophilia A. Lancet. 1992;340:1066–1067.CrossRefGoogle Scholar
  17. 17.
    Rossiter JP, Young M, Kimberland ML, et al. Factor VIII gene inversions causing severe hemophilia A originate almost exclusively in male germ cell. Hum Mol Genet. 1994;3:1035–1039.CrossRefGoogle Scholar
  18. 18.
    Tizzano EF, Domenech M, Baiget M. Inversion of intron 22 in isolated cases of severe hemophilia A. Thromb Haemost. 1995;73:6–9.Google Scholar
  19. 19.
    Weinmann AF, Schoof JM, Thompson AR. Clinical correlates among 49 families with hemophilia A and factor VIII gene inversions. Am J Hematol. 1996;51:192–199.CrossRefGoogle Scholar
  20. 20.
    Inaba H, Shibata H,Yoshida S, et al. Inversion in Japanese patients with hemophilia A [letter]. Thromb Haemost. 1995;74:810.PubMedGoogle Scholar
  21. 21.
    Goodeve AC, Preston EF, Peake IR.Factor VIII gene rearrangements in patients with severe haemophilia A. Lancet. 1994;343:329–330.CrossRefPubMedGoogle Scholar
  22. 22.
    Goodeve EC,William I, Brey GL, Peake IR. Relationship between factor VIII mutation type and inhibitor development in a cohort of previously untreated patients treated with recombinant factor VIII (Recombinate): Recombinate PUP Study Group. Thromb Haemost. 2000;83:844–848.CrossRefPubMedGoogle Scholar
  23. 23.
    Valleix S,Nafa K,Stietjes N, et al.Prevalence, male germ-line origin and new patterns of inversions in haemophilia A..Ann Genet. 1997;40:35–40.PubMedGoogle Scholar
  24. 24.
    Ljung RC, Sjorin E. Origin of mutation in sporadic cases of haemophilia A. Br J Haematol. 1999;106:870–874.CrossRefPubMedGoogle Scholar
  25. 25.
    Crow JF. The origins, patterns and implications of human spontaneous mutation. Nat Rev Genet. 2000;1:40–47.CrossRefPubMedGoogle Scholar
  26. 26.
    Pecorra M, Casarino L, Mori PG, et al. Hemophilia A: carrier detection and prenatal diagnosis byDNAanalysis. Blood. 1987;70:531–535.Google Scholar

Copyright information

© The Japanese Society of Hematology 2004

Authors and Affiliations

  • Kazuyoshi Fukuda
    • 1
  • Hiroyuki Naka
    • 1
  • Shogo Morichika
    • 1
  • Masaru Shibata
    • 1
  • Ichiro Tanaka
    • 1
  • Midori Shima
    • 1
  • Akira Yoshioka
    • 1
  1. 1.Department of PediatricsNara Medical UniversityNaraJapan

Personalised recommendations